|
|
Vaccine Detail
|
Cervarix |
| Vaccine Information |
- Vaccine Name: Cervarix
- Target Pathogen: Human Papillomavirus
- Target Disease: HPV infection
- Product Name: Human Papillomavirus Bivalent (Types 16 and 18) Vaccine, Recombinant
- Tradename: Cervarix
- Manufacturer: GlaxoSmithKline Biologicals
- Vaccine Ontology ID: VO_0011559
- CDC CVX code: 118
- Type: Inactivated or "killed" vaccine
- Status: Licensed
- Location Licensed: USA
- Host Species for Licensed Use: Human
- Adjuvant: AS04 vaccine adjuvant
- Preparation: prepared by combining the adsorbed VLPs of each HPV type together with the AS04 adjuvant system in sodium chloride, sodium dihydrogen phosphate dihydrate, and water for Injection (FDA: Cevarix).
- Immunization Route: Intramuscular injection (i.m.)
- Storage: Store refrigerated between 2º and 8ºC (36º and 46ºF). Do not freeze.
- Approved Age for Licensed Use: Females ages 10 to 25
|
| Host Response |
|
|
| References |
FDA: Cevarix: FDA: Cervarix [http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm186957.htm]
|
|
